NEXGEL, INC. Increase (Decrease) in Due to Related Parties
NEXGEL, INC. (NXGL) reported Increase (Decrease) in Due to Related Parties of $9.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2026-08-17
- NEXGEL, INC. increase (decrease) in due to related parties for the quarter ending 2026-06-30 was -$29.00K.
- NEXGEL, INC. increase (decrease) in due to related parties for the quarter ending 2026-03-31 was $38.00K.
- NEXGEL, INC. increase (decrease) in due to related parties for the quarter ending 2025-12-31 was $145.00K.
- NEXGEL, INC. increase (decrease) in due to related parties for the quarter ending 2025-09-30 was -$26.00K.
- NEXGEL, INC. increase (decrease) in due to related parties for fiscal 2025 was $35.00K.
- NEXGEL, INC. increase (decrease) in due to related parties for fiscal 2024 was -$123.00K, a 118.81% decline from fiscal 2023.
- NEXGEL, INC. increase (decrease) in due to related parties for fiscal 2023 was $654.00K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $9.00K 10-Q · filed 2026-08-17 | $154.00K derived: sum of 3 quarters · filed 2026-08-17 | $128.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $38.00K 10-Q · filed 2026-05-14 | $183.00K derived: sum of 2 quarters · filed 2026-05-14 | $157.00K derived: sum of 3 quarters · filed 2026-05-14 | $105.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $119.00K derived: sum of 2 quarters · filed 2026-03-31 | $67.00K derived: sum of 3 quarters · filed 2026-08-17 | $35.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$78.00K derived: sum of 2 quarters · filed 2026-08-17 | -$110.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$84.00K 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | -$32.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$123.00K 10-K · filed 2026-03-31 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$105.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$105.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $654.00K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |